This inventor holds 1 USPTO granted patent. Top assignee: Parker Hughes Institute. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Christopher S. Navara: Innovator in Anti-Proliferative Agents
Introduction
Christopher S. Navara is an accomplished inventor based in Plymouth, MN (US). He has made significant contributions to the field of biochemistry, particularly in the development of anti-proliferative agents. His innovative work focuses on the use of vanadium compounds to disrupt cell division processes.
Latest Patents
Navara holds a patent for "Vanadium Compounds as Anti-Proliferative Agents." This patent describes how these compounds can effectively prevent cell mitosis and meiosis by disrupting mitotic and meiotic spindle formation. The implications of this research are profound, as it opens new avenues for cancer treatment and other medical applications.
Career Highlights
Christopher S. Navara is currently associated with the Parker Hughes Institute, where he continues to advance his research. His work has garnered attention for its potential to impact therapeutic strategies in oncology and cell biology.
Collaborations
Navara collaborates with various professionals in his field, including his coworker Faith M. Uckun. Their combined expertise contributes to the innovative research being conducted at the Parker Hughes Institute.
Conclusion
Christopher S. Navara's contributions to the field of anti-proliferative agents highlight the importance of innovative research in medicine. His work with vanadium compounds represents a significant step forward in understanding and potentially treating diseases related to cell proliferation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile